
David M Rind MD
Assistant Clinical Professor of Medicine, Beth Israel Deaconess Medical
Join to View Full Profile
Beth Israel Deaconess Medical Center330 Brookline AvenueBoston, MA 02215
Phone+1 617-667-2700
Fax+1 617-667-6405
Are you Dr. Rind?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Rind, MD is a board certified internist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Assistant Clinical Professor of Medicine at Beth Israel Deaconess Medical.
Education & Training
- UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
- University of Rochester School of Medicine and DentistryClass of 1986
Certifications & Licensure
- MA State Medical License 1987 - 2027
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Evaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA.Jyotirmoy Sarker, Jeffrey A Tice, David M Rind, Surrey M Walton
Applied Health Economics and Health Policy. 2024-12-02 - 3 citationsA network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia.Abigail C Wright, Avery McKenna, Jeffrey A Tice, David M Rind, Foluso Agboola
Schizophrenia Research. 2024-12-01 - Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch.Marina Richardson, Abigail C Wright, Jeffrey A Tice, David M Rind, Matt Seidner
Value in Health. 2024-11-01
Press Mentions
- Hope, Caution for Washington State Patients 'First in Line' for New Schizophrenia DrugApril 7th, 2025
- How a Leftist Activist Group Helped Torpedo a Psychedelic TherapyFebruary 4th, 2025
- FDA Approves New Type of Nonopioid Painkiller for Acute PainJanuary 30th, 2025
- Join now to see all